Cargando…

Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ(42) Oligomers and Protect Synapses

Impaired synaptic integrity and function due to accumulation of amyloid β-protein (Aβ(42)) oligomers is thought to be a major contributor to cognitive decline in Alzheimer's disease (AD). However, the exact role of Aβ(42) oligomers in synaptotoxicity and the ability of peripheral innate immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Songlin, Hayden, Eric Y., Garcia, Veronica J., Fuchs, Dieu-Trang, Sheyn, Julia, Daley, David A., Rentsendorj, Altan, Torbati, Tania, Black, Keith L., Rutishauser, Ueli, Teplow, David B., Koronyo, Yosef, Koronyo-Hamaoui, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005081/ https://www.ncbi.nlm.nih.gov/pubmed/32082319 http://dx.doi.org/10.3389/fimmu.2020.00049

Ejemplares similares

Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ(42) Assemblies
por: Zuroff, Leah R., et al.
Publicado: (2020)

The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition
por: Danziger, Ron, et al.
Publicado: (2023)

Retinal Vasculopathy in Alzheimer’s Disease
por: Shi, Haoshen, et al.
Publicado: (2021)

Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
por: Kasindi, Arielle, et al.
Publicado: (2022)

Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020)

Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
por: Shi, Haoshen, et al.
Publicado: (2020)

Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
por: Doustar, Jonah, et al.
Publicado: (2020)

Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis
por: Rentsendorj, Altan, et al.
Publicado: (2023)

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Doustar, Jonah, et al.
Publicado: (2017)

Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
por: Shi, Haoshen, et al.
Publicado: (2020)

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau
por: Du, Xiaoxi, et al.
Publicado: (2022)

Color and contrast vision in mouse models of aging and Alzheimer’s disease using a novel visual-stimuli four-arm maze
por: Vit, Jean-Philippe, et al.
Publicado: (2021)

Ocular indicators of Alzheimer’s: exploring disease in the retina
por: Hart, Nadav J., et al.
Publicado: (2016)

Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer’s disease mice
por: Lahiri, Shouri, et al.
Publicado: (2019)

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
por: Zuroff, Leah, et al.
Publicado: (2017)

T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease
por: Wheeler, Christopher J, et al.
Publicado: (2014)

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3(+) neurodegenerative microglia
por: Shi, Haoshen, et al.
Publicado: (2022)

Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline
por: Dumitrascu, Oana M., et al.
Publicado: (2020)

Retinal pathological features and proteome signatures of Alzheimer’s disease
por: Koronyo, Yosef, et al.
Publicado: (2023)

Detection of retinal and blood Aβ oligomers with nanobodies
por: Habiba, Umma, et al.
Publicado: (2021)

Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study
por: Dumitrascu, Oana M., et al.
Publicado: (2021)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

Functional recreation of age-related CD8 T cells in young mice identifies drivers of aging- and human-specific tissue pathology
por: Panwar, Akanksha, et al.
Publicado: (2020)

Editorial: Role of Inflammation in Neurodegenerative Diseases
por: Koronyo-Hamaoui, Maya, et al.
Publicado: (2022)

Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer’s, and Tumor Mouse Models
por: Israel, Liron L., et al.
Publicado: (2022)

Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS
por: Finkelstein, Arseny, et al.
Publicado: (2011)

Aβ oligomers: role at the synapse
por: Puzzo, Daniela
Publicado: (2019)

Melanopsin retinal ganglion cell loss in Alzheimer disease
por: La Morgia, Chiara, et al.
Publicado: (2015)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)

Capping of Aβ42 Oligomers by Small Molecule Inhibitors
por: Fu, Ziao, et al.
Publicado: (2014)

Effect of Lauric Acid on the Stability of Aβ(42) Oligomers
por: Khatua, Prabir, et al.
Publicado: (2021)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Enhanced neuronal degradation of amyloid-β oligomers allows synapse regeneration
por: Bate, Clive
Publicado: (2015)

Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
por: Ferrari, Elena, et al.
Publicado: (2023)

Systemic interleukin-6 inhibition ameliorates acute neuropsychiatric phenotypes in a murine model of acute lung injury
por: Anwar, Faizan, et al.
Publicado: (2022)

Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
por: Ahmed, Mahiuddin, et al.
Publicado: (2010)

Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution
por: Wolff, Martin, et al.
Publicado: (2017)

Interaction of Aβ42 with Membranes Triggers the Self-Assembly into Oligomers
por: Banerjee, Siddhartha, et al.
Publicado: (2020)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0dn9diubsev6gnkimmdfuevcqu